Literature DB >> 29545723

Coordinated transcription of ANRIL and P16 genes is silenced by P16 DNA methylation.

Ying Gan1, Wanru Ma1, Xiuhong Wang1, Juanli Qiao1, Baozhen Zhang1, Chenghua Cui1, Zhaojun Liu1, Dajun Deng1.   

Abstract

OBJECTIVE: To investigate the relationship between the transcription of ANRIL, P15, P14 and P16 at the same locus and the regulation mechanism of ANRIL.
METHODS: Publicly available database of Cancer Cell Line Encyclopedia (CCLE) was used in bioinformatic analyses. Methylation of CpG islands was detected by denaturing high performance liquid chromatography (DHPLC). Gene transcript levels were determined using quantitative real-time polymerase chain reaction (qRT-PCR) assays. An engineered P16-specific transcription factor and DNA methyltransferase were used to induce P16-specific DNA demethylation and methylation.
RESULTS: The expression level of ANRIL was positively and significantly correlated with that of P16 but not with that of P15 in the CCLE database. This was confirmed in human cell lines and patient colon tissue samples. In addition, ANRIL was significantly upregulated in colon cancer tissues. Transcription of ANRIL and P16 was observed only in cell lines in which the P16 alleles were unmethylated and not in cell lines with fully methylated P16 alleles. Notably, P16-specific methylation significantly decreased transcription of P16 and ANRIL in BGC823 and GES1 cells. In contrast, P16-specific demethylation re-activated transcription of ANRIL and P16 in H1299 cells (P<0.001). Alteration ofANRIL expression was not induced by P16 expression changes.
CONCLUSIONS: ANRIL and P16 are coordinately transcribed in human cells and regulated by the methylation status of the P16 CpG islands around the transcription start site.

Entities:  

Keywords:  ANRIL; CpG island; DNA methylation; P16; transcriptional regulation

Year:  2018        PMID: 29545723      PMCID: PMC5842237          DOI: 10.21147/j.issn.1000-9604.2018.01.10

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  42 in total

1.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

2.  Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway.

Authors:  Guohui Wan; Rohit Mathur; Xiaoxiao Hu; Yunhua Liu; Xinna Zhang; Guang Peng; Xiongbin Lu
Journal:  Cell Signal       Date:  2013-02-14       Impact factor: 4.315

3.  Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene.

Authors:  Y Kotake; T Nakagawa; K Kitagawa; S Suzuki; N Liu; M Kitagawa; Y Xiong
Journal:  Oncogene       Date:  2010-12-13       Impact factor: 9.867

4.  ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.

Authors:  Shiqiong Xu; Huixue Wang; Hui Pan; Yingyun Shi; Tianyuan Li; Shengfang Ge; Renbing Jia; He Zhang; Xianqun Fan
Journal:  Cancer Lett       Date:  2016-07-25       Impact factor: 8.679

5.  Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

Authors:  Francesca Carozzi; Anna Gillio-Tos; Massimo Confortini; Annarosa Del Mistro; Cristina Sani; Laura De Marco; Salvatore Girlando; Stefano Rosso; Carlo Naldoni; Paolo Dalla Palma; Manuel Zorzi; Paolo Giorgi-Rossi; Nereo Segnan; Jack Cuzick; Guglielmo Ronco
Journal:  Lancet Oncol       Date:  2012-12-21       Impact factor: 41.316

6.  P16 Methylation as an Early Predictor for Cancer Development From Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study.

Authors:  Hongwei Liu; Xue-Wei Liu; Guangying Dong; Jing Zhou; Yang Liu; Yan Gao; Xiao-Yong Liu; Liankun Gu; Zheng Sun; Dajun Deng
Journal:  EBioMedicine       Date:  2015-03-23       Impact factor: 8.143

7.  The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma.

Authors:  Julie Steinestel; Andreas Al Ghazal; Annette Arndt; Thomas J Schnoeller; Andres J Schrader; Peter Moeller; Konrad Steinestel
Journal:  BMC Cancer       Date:  2015-04-03       Impact factor: 4.430

8.  Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans.

Authors:  Lesca M Holdt; Anika Stahringer; Kristina Sass; Garwin Pichler; Nils A Kulak; Wolfgang Wilfert; Alexander Kohlmaier; Andreas Herbst; Bernd H Northoff; Alexandros Nicolaou; Gabor Gäbel; Frank Beutner; Markus Scholz; Joachim Thiery; Kiran Musunuru; Knut Krohn; Matthias Mann; Daniel Teupser
Journal:  Nat Commun       Date:  2016-08-19       Impact factor: 14.919

9.  Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a.

Authors:  Er-bao Zhang; Rong Kong; Dan-dan Yin; Liang-hui You; Ming Sun; Liang Han; Tong-peng Xu; Rui Xia; Jin-song Yang; Wei De; Jin fei Chen
Journal:  Oncotarget       Date:  2014-04-30

10.  The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer.

Authors:  Jun-Jun Qiu; Yan Wang; Ying-Lei Liu; Ying Zhang; Jing-Xin Ding; Ke-Qin Hua
Journal:  Oncotarget       Date:  2016-05-31
View more
  9 in total

1.  DNA hydroxymethylation increases the susceptibility of reactivation of methylated P16 alleles in cancer cells.

Authors:  Paiyun Li; Ying Gan; Sisi Qin; Xiao Han; Chenghua Cui; Zhaojun Liu; Jing Zhou; Liankun Gu; Zhe-Ming Lu; Baozhen Zhang; Dajun Deng
Journal:  Epigenetics       Date:  2019-12-04       Impact factor: 4.528

2.  High Positive Correlations between ANRIL and p16-CDKN2A/p15-CDKN2B/p14-ARF Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an ANRIL-ARF Bidirectional Promoter.

Authors:  Kinan Drak Alsibai; Sophie Vacher; Didier Meseure; Andre Nicolas; Marick Lae; Anne Schnitzler; Walid Chemlali; Jerome Cros; Elisabeth Longchampt; Wulfran Cacheux; Geraldine Pignot; Celine Callens; Eric Pasmant; Yves Allory; Ivan Bieche
Journal:  Noncoding RNA       Date:  2019-08-21

3.  Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells.

Authors:  Wanru Ma; Juanli Qiao; Jing Zhou; Liankun Gu; Dajun Deng
Journal:  Mol Cancer       Date:  2020-02-27       Impact factor: 27.401

4.  Genetic and epigenetic associations of ANRIL with coronary artery disease and risk factors.

Authors:  Bayi Xu; Zhixia Xu; Yequn Chen; Nan Lu; Zhouwu Shu; Xuerui Tan
Journal:  BMC Med Genomics       Date:  2021-10-06       Impact factor: 3.063

5.  p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening.

Authors:  Qin Han; Hongyan Guo; Li Geng; Yanjie Wang
Journal:  Chin J Cancer Res       Date:  2020-04       Impact factor: 5.087

Review 6.  ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease.

Authors:  Yahui Kong; Chih-Heng Hsieh; Laura C Alonso
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-24       Impact factor: 5.555

7.  Methylenetetrahydrofolate Dehydrogenase 1 Silencing Expedites the Apoptosis of Non-Small Cell Lung Cancer Cells via Modulating DNA Methylation.

Authors:  Ke Ding; Jianyang Jiang; Liang Chen; Xiaohua Xu
Journal:  Med Sci Monit       Date:  2018-10-21

8.  A similar effect of P16 hydroxymethylation and true-methylation on the prediction of malignant transformation of oral epithelial dysplasia: observation from a prospective study.

Authors:  Hongwei Liu; Zhaojun Liu; Xue-Wei Liu; Si Xu; Lei Wang; Yang Liu; Jing Zhou; Liankun Gu; Yan Gao; Xiao-Yong Liu; Huidong Shi; Zheng Sun; Dajun Deng
Journal:  BMC Cancer       Date:  2018-09-24       Impact factor: 4.430

9.  P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib.

Authors:  Paiyun Li; Xuehong Zhang; Liankun Gu; Jing Zhou; Dajun Deng
Journal:  PLoS One       Date:  2019-10-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.